Maximus (NYSE:MMS) Hits New 1-Year Low – Time to Sell?

Maximus, Inc. (NYSE:MMS) shares hit a new 52-week low during trading on Tuesday . The company traded as low as $52.73 and last traded at $53.3310, with a volume of 272952 shares changing hands. The stock had previously closed at $54.46.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings lowered Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Finally, Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company currently has a consensus rating of “Hold”.

Maximus Stock Up 2.2%

The firm’s 50 day moving average price is $60.85 and its two-hundred day moving average price is $73.22. The company has a market cap of $2.89 billion, a P/E ratio of 8.25 and a beta of 0.60. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.21 and a current ratio of 2.21.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.98 by $0.09. The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.32 billion. Maximus had a net margin of 7.02% and a return on equity of 25.10%. Maximus’s revenue was down 4.1% on a year-over-year basis. During the same period in the prior year, the firm earned $2.01 earnings per share. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Equities research analysts anticipate that Maximus, Inc. will post 8.43 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were paid a $0.33 dividend. The ex-dividend date was Friday, May 15th. This represents a $1.32 annualized dividend and a dividend yield of 2.4%. Maximus’s dividend payout ratio (DPR) is currently 19.76%.

Institutional Trading of Maximus

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Royal Bank of Canada boosted its holdings in Maximus by 146.2% in the first quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock worth $1,345,000 after acquiring an additional 11,716 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after purchasing an additional 221 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Maximus by 7.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock worth $12,321,000 after purchasing an additional 11,754 shares during the period. Jane Street Group LLC lifted its holdings in shares of Maximus by 941.2% in the 1st quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock worth $6,701,000 after purchasing an additional 88,835 shares in the last quarter. Finally, Sivia Capital Partners LLC bought a new position in shares of Maximus in the 2nd quarter worth $204,000. 97.21% of the stock is owned by institutional investors.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.